CIRM Funded Clinical Trials
AB-205-301 Phase 3 Trial and Related Activities to Support Clinical Development of AB-205
AB-205-301 Phase 3 Trial and Related Activities to Support Clinical Development of AB-205
Disease Area:
B cell cancers
Investigator:
Institution:
CIRM Grant:
Award Value:
$15,000,000
Trial Sponsor:
Angiocrine Bioscience, Inc.
Trial Stage:
Phase 3
Trial Status:
Recruiting
Targeted Enrollment:
148
ClinicalTrials.gov ID:
